πŸ‡ΊπŸ‡Έ FDA
Patent

US 6436989

Prodrugs of aspartyl protease inhibitors

expired A61PA61P31/12A61P31/18

Quick answer

US patent 6436989 (Prodrugs of aspartyl protease inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 20 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P31/12, A61P31/18, A61P43/00